We have evidence that Akt signaling is involved in both the CD97-induced strengthening of adherens junctions and in the migration of tumor cells: specific inhibitors of the phosphoinositide-3 kinase (PIK3)/Akt pathway stopped CD97-induced random tumor migration [28]. Here, AKT1 is linked to neoplasm.